Hepatitis B Vaccine , Aluminium Hydroxide, Thiomersal

The Hepatitis B Vaccine, formulated with Aluminum Hydroxide and Thiomersal as adjuvants, is a critical preventive medication against Hepatitis B virus infection. The Hepatitis B virus, primarily transmitted through blood and sexual contact, can lead to acute illness and long-term chronic liver disease, such as cirrhosis and liver cancer. This vaccine is administered to individuals to stimulate the immune system’s production of protective antibodies, neutralizing the virus and preventing its entry into host cells. By receiving the Hepatitis B Vaccine, one can avoid the severe health consequences of a Hepatitis B infection.
The primary component of this vaccine is a genetically engineered version of the hepatitis B surface antigen, obtained through recombinant DNA technology. It is combined with adjuvants, Aluminum Hydroxide and Thiomersal, which aid in enhancing the immune response. The Aluminum Hydroxide acts as an adjuvant, amplifying the immune system’s response, while Thiomersal functions as a preservative, preventing contamination. This vaccine is administered as a series of injections, usually to newborns and high-risk individuals, to establish a lifelong immunity against the Hepatitis B virus.
The Hepatitis B Vaccine has been proven safe and effective for various age groups and is crucial for reducing the global burden of this preventable disease.